Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines

Glioblastoma is the most common primary brain tumor in humans and has a poor prognosis. Current therapies are not curative. Oncolytic viruses (OVs) are being investigated as tools to induce immunogenic cell death (ICD), cell death capable of activating the immune system. Semliki Forest Virus (SFV) s...

Full description

Bibliographic Details
Main Author: Sivaramakrishnan, Aishwarya
Format: Others
Language:English
Published: Uppsala universitet, Institutionen för immunologi, genetik och patologi 2021
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-446046
id ndltd-UPSALLA1-oai-DiVA.org-uu-446046
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-4460462021-09-17T05:26:11ZCharacterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell linesengSivaramakrishnan, AishwaryaUppsala universitet, Institutionen för immunologi, genetik och patologiUppsala universitet, Institutionen för biologisk grundutbildning2021GlioblastomaImmunogenic Cell DeathOncolytic VirusesSemliki Forest VirusAishwarya SivaramakrishnanCancer and OncologyCancer och onkologiGlioblastoma is the most common primary brain tumor in humans and has a poor prognosis. Current therapies are not curative. Oncolytic viruses (OVs) are being investigated as tools to induce immunogenic cell death (ICD), cell death capable of activating the immune system. Semliki Forest Virus (SFV) strain 4 is an OV being investigated to treat glioblastoma. Previous studies in our lab have shown that SFV4 can induce ICD in human osteosarcoma (HOS) cells and ongoing in vivo studies show that SFV4 infected GL261 cell vaccination providesprotective immunity in mouse models. This study aimed to characterize the ICD induced by SFV4in glioblastoma cell lines, namely GL261, SB28 and CT2A, and to explain some of our in vivoobservations, namely why vaccination with SFV infected GL261 provides protective immunity but vaccination with infected CT2A and SB28 does not. Our in vitro studies found that GL261 is resistant to SFV4 while SB28 and CT2A are susceptible. We show that the virus can replicate in all three cell lines as seen by the presence of dsRNA, but that viral translation is delayed or inhibited in GL261 cells as not all cells positive for dsRNA were positive for SFV4 protein. Additionally, the type I interferon (IFN) pathway, responsible for antiviral defense, was highly upregulated in CT2A and SB28 but not as much in GL261 after infectionas seen by surveying IFIT1, IFITM3 and IFN-beta genes. Interferon stimulated genes (ISG) like CXCL10, a chemoattractant, was highly upregulated in GL261 after infection and might account for the protective immunity seen in vivo after vaccination. PDL1, an interferon stimulated gene responsible for self-tolerance, was highly upregulated in CT2A after infection. The IFN-beta ELISA revealed that both infected and uninfected GL261 cells produce IFN-beta suggesting a constitutively active pathway. Our DC phagocytosis assay showed that SFV4 infection of CT2A and SB28 cells induced a significant increase in DC phagocytosis and SFV4 infection of all three cell lines significantly increased DC maturation. We conclude that SFV4 infection of GL261 cells may induce ICD in vivo through a persistent viral infection and increased expression of CXCL10.  Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-446046application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Others
sources NDLTD
topic Glioblastoma
Immunogenic Cell Death
Oncolytic Viruses
Semliki Forest Virus
Aishwarya Sivaramakrishnan
Cancer and Oncology
Cancer och onkologi
spellingShingle Glioblastoma
Immunogenic Cell Death
Oncolytic Viruses
Semliki Forest Virus
Aishwarya Sivaramakrishnan
Cancer and Oncology
Cancer och onkologi
Sivaramakrishnan, Aishwarya
Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines
description Glioblastoma is the most common primary brain tumor in humans and has a poor prognosis. Current therapies are not curative. Oncolytic viruses (OVs) are being investigated as tools to induce immunogenic cell death (ICD), cell death capable of activating the immune system. Semliki Forest Virus (SFV) strain 4 is an OV being investigated to treat glioblastoma. Previous studies in our lab have shown that SFV4 can induce ICD in human osteosarcoma (HOS) cells and ongoing in vivo studies show that SFV4 infected GL261 cell vaccination providesprotective immunity in mouse models. This study aimed to characterize the ICD induced by SFV4in glioblastoma cell lines, namely GL261, SB28 and CT2A, and to explain some of our in vivoobservations, namely why vaccination with SFV infected GL261 provides protective immunity but vaccination with infected CT2A and SB28 does not. Our in vitro studies found that GL261 is resistant to SFV4 while SB28 and CT2A are susceptible. We show that the virus can replicate in all three cell lines as seen by the presence of dsRNA, but that viral translation is delayed or inhibited in GL261 cells as not all cells positive for dsRNA were positive for SFV4 protein. Additionally, the type I interferon (IFN) pathway, responsible for antiviral defense, was highly upregulated in CT2A and SB28 but not as much in GL261 after infectionas seen by surveying IFIT1, IFITM3 and IFN-beta genes. Interferon stimulated genes (ISG) like CXCL10, a chemoattractant, was highly upregulated in GL261 after infection and might account for the protective immunity seen in vivo after vaccination. PDL1, an interferon stimulated gene responsible for self-tolerance, was highly upregulated in CT2A after infection. The IFN-beta ELISA revealed that both infected and uninfected GL261 cells produce IFN-beta suggesting a constitutively active pathway. Our DC phagocytosis assay showed that SFV4 infection of CT2A and SB28 cells induced a significant increase in DC phagocytosis and SFV4 infection of all three cell lines significantly increased DC maturation. We conclude that SFV4 infection of GL261 cells may induce ICD in vivo through a persistent viral infection and increased expression of CXCL10. 
author Sivaramakrishnan, Aishwarya
author_facet Sivaramakrishnan, Aishwarya
author_sort Sivaramakrishnan, Aishwarya
title Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines
title_short Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines
title_full Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines
title_fullStr Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines
title_full_unstemmed Characterizing the immunogenic cell death induced by Semliki Forest Virus in glioblastoma cell lines
title_sort characterizing the immunogenic cell death induced by semliki forest virus in glioblastoma cell lines
publisher Uppsala universitet, Institutionen för immunologi, genetik och patologi
publishDate 2021
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-446046
work_keys_str_mv AT sivaramakrishnanaishwarya characterizingtheimmunogeniccelldeathinducedbysemlikiforestvirusinglioblastomacelllines
_version_ 1719481394128748544